Related Experiment Video
Updated: Jun 30, 2026
06:55
Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis
Published on: February 13, 2026
Hepatic fibrogenesis: from within and outwith
Neil C Henderson1, Stuart J Forbes
1The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. Neil.Henderson@ed.ac.uk
Toxicology
|October 1, 2008
Summary
Liver disease is a growing cause of death. Understanding hepatic fibrogenesis and developing anti-fibrotic therapies are crucial for treating liver fibrosis and preventing end-stage liver disease.
Area of Science:
- Hepatology
- Cellular Biology
- Immunology
Background:
- Liver disease is the fifth leading cause of death in the UK, with increasing incidence.
- Chronic liver injury leads to fibrosis, cirrhosis, and severe complications like portal hypertension and liver cancer.
- Current treatments lack specific anti-fibrotic therapies, necessitating research into fibrogenesis mechanisms.
Purpose of the Study:
- To outline the cellular pathways of hepatic fibrogenesis.
- To discuss emerging cell sources involved in liver scarring.
- To explore the role of hepatic macrophages in liver fibrosis.
Main Methods:
- Review of cellular pathways in hepatic fibrogenesis.
- Discussion of emerging scar-forming cell populations.
- Analysis of the regulatory function of hepatic macrophages.
Main Results:
- Hepatic stellate cell activation is a key pathway in fibrogenesis, leading to collagen production.
- New cellular sources contributing to liver scarring are identified.
- Hepatic macrophages play a dual role in regulating fibrosis formation and resolution.
Conclusions:
- Understanding hepatic stellate cell activation is vital for targeting liver fibrosis.
- Further research into novel cell sources and macrophage function may yield new anti-fibrotic strategies.
- Developing effective anti-fibrotic treatments is essential to combat the rising burden of liver disease.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
10:42Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Published on: May 13, 2016
Related Concept Videos
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:09Introduction to Fibroblasts
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
01:11Healing I: Introduction
Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...